Evolus (EOLS) Receivables - Other (2017 - 2018)

Evolus (EOLS) posted Receivables - Other of $100000.0 for Q1 2018, down 99.86% on a QoQ basis from $72.6 million in Q4 2017.

Evolus (EOLS) Receivables - Other (2017 - 2018) Analysis & Trends

Evolus' Receivables - Other history runs 2 years deep, the most recent figure standing at $100000.0 for Q1 2018.

Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $100000.0 (changed N/A YoY) and the FY2017 annual result came in at $72.6 million, changed N/A from the prior year.
Receivables - Other was $100000.0 for Q1 2018 at Evolus, down from $72.6 million in the prior quarter.
Across five years, Receivables - Other topped out at $72.6 million in Q4 2017 and bottomed at $100000.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Evolus	390.47 Mn	340.68 Mn	48.90 Mn

Download Data